Deroy & Devereaux Private Investment Counsel’s Amgen AMGN Stock Holding History

Deroy & Devereaux Private Investment Counsel’s Portfolio AMGN Stock Details AMGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q2	–	Sell	-1,040	Closed	-$211K	–	145
2020 Q1	$211K	Hold	1,040	–	–	0.03%	126
2019 Q4	$251K	Hold	1,040	–	–	0.02%	127
2019 Q3	$201K	Sell	1,040 -50	-5%	-$9.6K	0.02%	144
2019 Q2	$201K	Hold	1,090	–	–	0.02%	145
2019 Q1	$207K	Sell	1,090 -50	-4%	-$9.55K	0.02%	148
2018 Q4	$222K	Hold	1,140	–	–	0.03%	149
2018 Q3	$236K	Sell	1,140 -50	-4%	-$9.85K	0.02%	161
2018 Q2	$220K	Sell	1,190 -71	-6%	-$12.6K	0.02%	155
2018 Q1	$215K	Buy	+1,261	New	+$231K	0.02%	157

Other funds holding AMGN

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Nordea Investment Management Stockholm, Sweden $123B AUM 38.85% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Deroy & Devereaux Private Investment Counsel's AMGN Position: Q2 2020 in Review

Deroy & Devereaux Private Investment Counsel sold out of Amgen (AMGN) in Q2 2020, closing a stake of 1,040 shares — an estimated $211K sold.

Deroy & Devereaux Private Investment Counsel first reported a position in AMGN in Q1 2018 and held it in 9 quarters. The position peaked at $251K in Q4 2019. 2,091 funds tracked by Wall St. Rank hold AMGN as of Q2 2020.

Deroy & Devereaux Private Investment Counsel reported no remaining Amgen position as of Q2 2020 after selling out during the quarter.
Deroy & Devereaux Private Investment Counsel sold 1,040 Amgen shares in Q2 2020, an estimated $211K.
Deroy & Devereaux Private Investment Counsel first reported a position in Amgen in Q1 2018 and held it in 9 quarters.
Deroy & Devereaux Private Investment Counsel's Amgen position peaked at $251K in Q4 2019.
2,091 funds tracked by Wall St. Rank held Amgen as of Q2 2020.

Based on Deroy & Devereaux Private Investment Counsel's 13F filing for Q2 2020, filed 20 Jul 2020.